These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26592813)

  • 1. New fluorinated agonists for targeting the sphingosin-1-phosphate receptor 1 (S1P(1)).
    Shaikh RS; Keul P; Schäfers M; Levkau B; Haufe G
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5048-51. PubMed ID: 26592813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of new ligands for targeting the S1P1 receptor.
    Schilson SS; Keul P; Shaikh RS; Schäfers M; Levkau B; Haufe G
    Bioorg Med Chem; 2015 Mar; 23(5):1011-26. PubMed ID: 25656338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
    Clemens JJ; Davis MD; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
    Oo ML; Thangada S; Wu MT; Liu CH; Macdonald TL; Lynch KR; Lin CY; Hla T
    J Biol Chem; 2007 Mar; 282(12):9082-9. PubMed ID: 17237497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.
    Vachal P; Toth LM; Hale JJ; Yan L; Mills SG; Chrebet GL; Koehane CA; Hajdu R; Milligan JA; Rosenbach MJ; Mandala S
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3684-7. PubMed ID: 16682185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015).
    Guerrero M; Urbano M; Roberts E
    Expert Opin Ther Pat; 2016; 26(4):455-70. PubMed ID: 26947494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs.
    Foss FW; Mathews TP; Kharel Y; Kennedy PC; Snyder AH; Davis MD; Lynch KR; Macdonald TL
    Bioorg Med Chem; 2009 Aug; 17(16):6123-36. PubMed ID: 19632123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosin-1-phosphate Receptor 1: a Potential Target to Inhibit Neuroinflammation and Restore the Sphingosin-1-phosphate Metabolism.
    Kolahdooz Z; Nasoohi S; Asle-Rousta M; Ahmadiani A; Dargahi L
    Can J Neurol Sci; 2015 May; 42(3):195-202. PubMed ID: 25860537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-phosphate receptor agonists: a patent review (2010-2012).
    Roberts E; Guerrero M; Urbano M; Rosen H
    Expert Opin Ther Pat; 2013 Jul; 23(7):817-41. PubMed ID: 23541049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
    Samuvel DJ; Saxena N; Dhindsa JS; Singh AK; Gill GS; Grobelny DW; Singh I
    PLoS One; 2015; 10(10):e0141781. PubMed ID: 26513477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.
    Li Z; Chen W; Hale JJ; Lynch CL; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Parent SA; Bergstrom J; Card D; Forrest M; Quackenbush EJ; Wickham LA; Vargas H; Evans RM; Rosen H; Mandala S
    J Med Chem; 2005 Oct; 48(20):6169-73. PubMed ID: 16190743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
    Skidmore J; Heer J; Johnson CN; Norton D; Redshaw S; Sweeting J; Hurst D; Cridland A; Vesey D; Wall I; Ahmed M; Rivers D; Myatt J; Giblin G; Philpott K; Kumar U; Stevens A; Bit RA; Haynes A; Taylor S; Watson R; Witherington J; Demont E; Heightman TD
    J Med Chem; 2014 Dec; 57(24):10424-42. PubMed ID: 25431977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.
    Jo E; Sanna MG; Gonzalez-Cabrera PJ; Thangada S; Tigyi G; Osborne DA; Hla T; Parrill AL; Rosen H
    Chem Biol; 2005 Jun; 12(6):703-15. PubMed ID: 15975516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice.
    Tarrasón G; Aulí M; Mustafa S; Dolgachev V; Domènech MT; Prats N; Domínguez M; López R; Aguilar N; Calbet M; Pont M; Milligan G; Kunkel SL; Godessart N
    Int Immunopharmacol; 2011 Nov; 11(11):1773-9. PubMed ID: 21798372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Sphingosine 1-Phosphate Receptor 1 Agonist Is Protective Against Ischemia/Reperfusion in Mice.
    Brait VH; Tarrasón G; Gavaldà A; Godessart N; Planas AM
    Stroke; 2016 Dec; 47(12):3053-3056. PubMed ID: 27827329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
    Imeri F; Fallegger D; Zivkovic A; Schwalm S; Enzmann G; Blankenbach K; Meyer zu Heringdorf D; Homann T; Kleuser B; Pfeilschifter J; Engelhardt B; Stark H; Huwiler A
    Neuropharmacology; 2014 Oct; 85():314-27. PubMed ID: 24863045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S1P receptor mediated activity of FTY720 phosphate mimics.
    Högenauer K; Hinterding K; Nussbaumer P
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1485-7. PubMed ID: 20153186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate.
    Sanna MG; Liao J; Jo E; Alfonso C; Ahn MY; Peterson MS; Webb B; Lefebvre S; Chun J; Gray N; Rosen H
    J Biol Chem; 2004 Apr; 279(14):13839-48. PubMed ID: 14732717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.